title: The impact of rheumatoid arthritis and biologics on employers and payers.
abstract: Paresh Chaudhari, PharmD, MPH, frames the business case for employers to look beyond the direct medical costs of treatment of RA and consider employee health benefits as an investment.
authors.forename: Paresh
authors.initials: P
authors.lastname: Chaudhari